99mTc/188Re-labeled single-domain antibody targeting HER2

HER2-targeted single-domain antibody labeled with technetium-99m and rhenium-188 · Shanghai General Hospital; Shanghai Jiao Tong University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 99mTc/188Re-labeled single-domain antibody targeting HER2, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody [EARLY_Phase 1]

See pricing